Insulet Corporation (PODD) Announces Strategic Expansion and Supply Agreement Update

Insulet Corporation (NASDAQ:PODD) is one of the best medical technology stocks to invest in. On February 5, Insulet Corporation (NASDAQ:PODD) announced that its Omnipod 5 Automated Insulin Delivery (AID) system is now commercially available in the Middle East. The specific countries mentioned were the United Arab Emirates (UAE), Saudi Arabia, Qatar, and Kuwait.

Pixabay/Public Domain

According to Insulet, the Omnipod 5 system automatically adjusts insulin delivery every five minutes. It achieves this by communicating with compatible continuous glucose monitoring sensors and is designed to eliminate the need for multiple daily injections, simplifying diabetes management, noted Insulet.

The company also launched Omnipod Discover, a web-based data management and analytics platform for users, caregivers, and healthcare providers. It organizes and visualizes glucose and insulin delivery data to support diabetes care decisions.

In a separate update, on February 3, Insulet entered into an addendum to its existing Purchase Agreement with NXP USA, Inc. The addendum is effective from January 1, 2026, and extends a long-term supply arrangement that was originally established on October 12, 2017.

Some of the elements amended in the updated agreement include pricing terms, product volume commitments, and product order flexibility. Others are contractual conditions that affect Insulet’s supply chain planning.

According to Insulet, the updated terms are intended to maintain continuity of supply for components used in its medical devices. They also provide revised commercial terms that may affect cost structure and operational flexibility.

Insulet Corporation (NASDAQ:PODD) designs, manufactures, and sells insulin delivery systems for people with diabetes. Its flagship product is the Omnipod Insulin Management System, a tubeless, wearable insulin pump that provides continuous subcutaneous insulin infusion and integrates with glucose monitoring technologies.

While we acknowledge the potential of PODD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Foreign Stocks to Buy Right Now and 11 Best AI Penny Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.